EE04179B1 - Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides - Google Patents

Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides

Info

Publication number
EE04179B1
EE04179B1 EE9700249A EE9700249A EE04179B1 EE 04179 B1 EE04179 B1 EE 04179B1 EE 9700249 A EE9700249 A EE 9700249A EE 9700249 A EE9700249 A EE 9700249A EE 04179 B1 EE04179 B1 EE 04179B1
Authority
EE
Estonia
Prior art keywords
pharmaceutical formulations
digestive enzyme
stabilizing additives
enzyme mixtures
compound lipids
Prior art date
Application number
EE9700249A
Other languages
English (en)
Estonian (et)
Other versions
EE9700249A (et
Inventor
Galle Manfred
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of EE9700249A publication Critical patent/EE9700249A/xx
Publication of EE04179B1 publication Critical patent/EE04179B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
EE9700249A 1996-08-28 1997-08-28 Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides EE04179B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19634752 1996-08-28
DE19724845A DE19724845A1 (de) 1996-08-28 1997-06-12 Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen

Publications (2)

Publication Number Publication Date
EE9700249A EE9700249A (et) 1998-04-15
EE04179B1 true EE04179B1 (et) 2003-12-15

Family

ID=26028823

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700249A EE04179B1 (et) 1996-08-28 1997-08-28 Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides

Country Status (21)

Country Link
US (1) US5993806A (cs)
EP (1) EP0826375B1 (cs)
JP (1) JP4593697B2 (cs)
CN (1) CN1199694C (cs)
AR (1) AR008807A1 (cs)
AT (1) ATE284225T1 (cs)
AU (1) AU722151B2 (cs)
BR (1) BR9704554B1 (cs)
CA (1) CA2213151C (cs)
CZ (1) CZ295329B6 (cs)
DE (2) DE19724845A1 (cs)
DK (1) DK0826375T3 (cs)
EE (1) EE04179B1 (cs)
ES (1) ES2235206T3 (cs)
HU (1) HUP9701437A3 (cs)
NO (1) NO973940L (cs)
NZ (1) NZ328616A (cs)
PL (1) PL190140B1 (cs)
PT (1) PT826375E (cs)
SK (1) SK284639B6 (cs)
TR (1) TR199700872A3 (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074689A (en) * 1998-03-10 2000-06-13 Immucell Corporation Colonic delivery of protein or peptide compositions
KR100367659B1 (ko) * 2000-05-08 2003-01-14 주식회사 바이넥스 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법
GB0019118D0 (en) * 2000-08-03 2000-09-27 Danisco Solid phase glycerolysis
ATE295737T1 (de) * 2000-11-02 2005-06-15 Cilian Ag Verwendung von aus ciliaten gewonnenen enzymen als verdauungsfördernde arzneimittel
US20030099626A1 (en) * 2001-11-20 2003-05-29 Health Education Corporation Nutrient absorption enhancing compositions and methods
CA2560613C (en) * 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
US7153504B2 (en) * 2004-07-30 2006-12-26 Can Technologies, Inc. Stabilized pancreas product
WO2007012069A2 (en) * 2005-07-20 2007-01-25 Brophy James S Modification of particle morphology to improve product functionality
HUE031042T2 (en) 2005-07-29 2017-06-28 Abbott Laboratories Gmbh Methods for producing pancreatin powder with low viral content
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20110183050A1 (en) * 2006-07-20 2011-07-28 Brophy James S Modification of particle morphology to improve product functionality
US8444967B2 (en) 2010-07-09 2013-05-21 Master Supplements, Inc. Treatment including prebiotic composition for use with probiotics
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
DE102009006594A1 (de) 2009-01-29 2010-08-05 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutisches Präparat
BRPI0922653B8 (pt) 2009-01-29 2021-05-25 Nordmark Arzneimittel Gmbh & Co Kg uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa
UA111726C2 (uk) 2010-10-01 2016-06-10 Апталіс Фарма Лімітед Препарат панкреліпази низької сили з кишковорозчинним покриттям
MX2016001593A (es) 2013-08-09 2016-09-29 Allergan Pharmaceuticals Int Ltd Composicion de enzima digestiva adecuada para administracion enterica.
MX2016000480A (es) * 2013-11-05 2016-10-21 Allergan Pharmaceuticals Int Ltd Composiciones farmaceuticas de pancreatina de alta potencia.
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
WO2016071434A1 (en) * 2014-11-05 2016-05-12 Abbott Laboratories Gmbh Processes for producing compositions with improved safety profile comprising pancreatin and compositions suitable for pharmaceutical use
WO2016126970A1 (en) 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung
DE102015114862A1 (de) * 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung, enthaltend eine bakterielle Lipase

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956483A (en) * 1968-10-24 1976-05-11 Wilson Pharmaceutical & Chemical Corporation Preparing pancreatin
US3991180A (en) * 1972-03-06 1976-11-09 Rohm And Haas Company Stabilization of internally administered pancreatic lipase
DE2512746C3 (de) * 1975-03-22 1980-04-24 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin
GB1603640A (en) * 1977-07-20 1981-11-25 Gist Brocades Nv Enzyme particles
JPS58148814A (ja) * 1982-03-01 1983-09-05 Fujimoto Seiyaku Kk 消化酵素軟カプセル剤
JPS59169491A (ja) * 1983-03-15 1984-09-25 Duskin Franchise Co Ltd 酵素の安定化法
JPH0229950A (ja) * 1988-07-18 1990-01-31 Nec Corp 光ディスク
JP2679852B2 (ja) * 1989-11-29 1997-11-19 株式会社サム研究所 経口及び局所投与用生物活性蛋白組成物
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
CA2101274C (en) * 1991-01-24 1998-12-15 David J. Kyle Microbial oil mixtures and uses thereof
DE4200002A1 (de) * 1992-01-02 1993-07-08 Rudolf V Dipl Chem Dr Noronha Reinigungstablette fuer die zahnprothesen
EP0719133A1 (en) * 1993-09-15 1996-07-03 Unilever Plc Skin care method and composition
JPH09125096A (ja) * 1995-10-30 1997-05-13 Koei Sangyo:Kk 液状天然油脂洗剤

Also Published As

Publication number Publication date
BR9704554A (pt) 1998-09-15
CA2213151C (en) 2008-04-01
US5993806A (en) 1999-11-30
PL321825A1 (en) 1998-03-02
ES2235206T3 (es) 2005-07-01
ATE284225T1 (de) 2004-12-15
SK284639B6 (sk) 2005-08-04
EP0826375A2 (de) 1998-03-04
EP0826375B1 (de) 2004-12-08
AU722151B2 (en) 2000-07-20
NO973940L (no) 1998-03-02
AR008807A1 (es) 2000-02-23
JPH1077236A (ja) 1998-03-24
HUP9701437A3 (en) 2001-03-28
HUP9701437A2 (hu) 1998-03-30
DE19724845A1 (de) 1998-03-05
NZ328616A (en) 1999-01-28
HK1005224A1 (en) 1998-12-31
CZ218497A3 (cs) 1998-03-18
BR9704554B1 (pt) 2011-12-27
HU9701437D0 (en) 1997-10-28
TR199700872A2 (xx) 1999-04-21
AU3530997A (en) 1998-03-05
CZ295329B6 (cs) 2005-07-13
CN1199694C (zh) 2005-05-04
EE9700249A (et) 1998-04-15
DE59712108D1 (de) 2005-01-13
DK0826375T3 (da) 2005-01-24
NO973940D0 (no) 1997-08-27
SK115997A3 (en) 1998-07-08
JP4593697B2 (ja) 2010-12-08
PT826375E (pt) 2005-02-28
CN1174743A (zh) 1998-03-04
PL190140B1 (pl) 2005-11-30
EP0826375A3 (de) 2002-08-14
TR199700872A3 (tr) 1999-04-21
CA2213151A1 (en) 1998-02-28

Similar Documents

Publication Publication Date Title
EE04179B1 (et) Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides
PT769965E (pt) Formulacoes aquosas de risperidona
NO980126D0 (no) Plaster-formulering for perkantal administrering av fenantyl
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
FI964583L (fi) Tokoferolikoostumuksia biologisesti aktiivisten aineiden antamiseksi
IS6205A (is) Lyfja- og næringarsamsetningar sem innihalda nauðsynlegar fitusýrur og hómósystein-lækkandi miðla
DE69822839D1 (de) Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
AT503376A3 (de) Synergistische spot-on-formulierung
HUP0000575A3 (en) Novel formulation comprising budesonid as active indegredient
FI971776L (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
NO952357D0 (no) Formulering av insulinanaloger
PT907364E (pt) Composicao farmaceutica de libertacao sustida
EP0785772A4 (en) LYOPHILISATE OF A LIPID COMPLEX OF WATER-INSOLUBLE CAMTOTHECINS
NO990435D0 (no) Fremstilling av estere som overflateaktive midler
NO981166D0 (no) Fremstilling av askorbylmonofosfater
DE59711379D1 (de) Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren
BR9800440A (pt) Preparação de preparações de sabor disfarçado de derivados de quinolona antibacterianamente ativos
FI953887A7 (fi) Kefaklorin farmaseuttisia formulaatioita
IL133176A0 (en) Pharmaceutical compositions of peptides having low solubility in physiological medium
NO20003105D0 (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
PT925273E (pt) Composicoes farmaceuticas contendo acidos 4-oxobutanoicos
IL127691A0 (en) Useful formulations of acid addition salt drugs
HUP0102705A2 (hu) alfa-Aminosav-fenil-észterszármazékok és alkalmazásuk, valamint, e vegyületeket tartalmazó gyógyászati készítmények
IT1290003B1 (it) Uso di pivagabina per preparare composizioni farmaceutiche
ZA977308B (en) Use of complex lipids as stabilizing-additives to pharmaceutical preparations of digestive enzyme mixtures.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

MM4A Lapsed by not paying the annual fees

Effective date: 20060828